Global Psoriasis Market Report 2021 - Opportunities And Strategies, Market Forecast And Trends

14 Oct, 2021

The psoriasis drugs market consists of sales of psoriasis drugs. Psoriasis is a persistent skin disorder which causes distress and pain through patches of abnormal skin. Psoriasis can be caused due to injuries to skin, medications, genetics, infection, diet, weather, etc. The drugs vary depending on the severity of the infection and provide relief from infections. Examples of drugs in the psoriasis market include clobetasol (Temovate), triamcinolone (Aristocort), fluocinolone (Synalar), and betamethasone (Diprolene).

Global Psoriasis Market Size And Drivers:

The global psoriasis market is expected to grow from $15.06 billion in 2020 to $15.86 billion in 2021 at a compound annual growth rate (CAGR) of 5.3%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $21.97 billion in 2025 at a CAGR of 8.5%. The rise in the prevalence of psoriasis patients is driving the Psoriasis market.

Request For A Sample For The Global Psoriasis Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2414&type=smp

Trends In The Global Psoriasis Market

Combination therapy is an emerging trend in the psoriasis market. Combination therapy is an f treatment that combines two different psoriasis treatments at the same time. When two drugs with different mechanisms of action are combined (combination therapy), the effect is greater than that obtained by monotherapy (treatment with a single drug). Studies suggest that combination therapy eases psoriasis symptoms more effectively than a single therapy and has lesser side effects. An example of combination therapy for the treatment of active psoriatic arthritis (PsA) is taltz (ixekizumab) with methotrexate developed by Eli Lilly and Company.

Global Psoriasis Market Segments:
The global psoriasis market is further segmented –
By Drug class: Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor
By Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce
By Drug Types: Small molecules, Biologics
By Route Of Administration: Oral, Tropical, Injectable
By Disease Indication: Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis
By Geography: The global psoriasis market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Report For The Global Psoriasis Market At:

https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report

Psoriasis Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides psoriasis market overviews, analyzes and forecasts market size and growth for the global psoriasis market, psoriasis market share, psoriasis market players, psoriasis market segments and geographies, psoriasis market’s leading competitors’ revenues, profiles and market shares. The psoriasis market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.